Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial
…, S Luxmi, S Kumar, H Arain, M Khan, AS Khan… - …, 2021 - thelancet.com
Background Hyperimmune anti-COVID-19 Intravenous Immunoglobulin (C-IVIG) is an
unexplored therapy amidst the rapidly evolving spectrum of medical therapies for COVID-19 and …
unexplored therapy amidst the rapidly evolving spectrum of medical therapies for COVID-19 and …
[HTML][HTML] Real-Life clinical effectiveness of Razumab®(the world's first biosimilar of ranibizumab) in retinal vein occlusion: a subgroup analysis of the pooled …
Background: This subgroup analysis of the RE-ENACT study evaluates the effectiveness of
Razumab®(the world’s first biosimilar of ranibizumab by Intas Pharmaceuticals Ltd.) in Indian …
Razumab®(the world’s first biosimilar of ranibizumab by Intas Pharmaceuticals Ltd.) in Indian …
Corporate board for innovative managerial control: implications of corporate governance deviance perspective
Purpose Drawing from the firm’s entrepreneurial identity and ecology perspectives, this study
aims to explain why the firms deviate from standard corporate governance practices and …
aims to explain why the firms deviate from standard corporate governance practices and …
Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma
Background: This study assesses the feasibility of producing hyperimmune anti-COVID-19
intravenously administrable immunoglobulin (C-IVIG) from pooled convalescent plasma (PCP…
intravenously administrable immunoglobulin (C-IVIG) from pooled convalescent plasma (PCP…
A multicenter, retrospective study (RE-ENACT 2) on the use of Razumab™(world's first biosimilar ranibizumab) in wet age-related macular degeneration
S Sharma, M Khan, A Chaturvedi… - Ophthalmology and …, 2020 - Springer
Introduction The REal life assessmENt of safety And effeCTiveness of Razumab (RE-ENACT)
and long-term RE-ENACT 2 retrospective studies have evaluated the use of Razumab™ (…
and long-term RE-ENACT 2 retrospective studies have evaluated the use of Razumab™ (…
Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder
A Ahmad, S Sheikh, MA Khan, A Chaturvedi… - Bipolar …, 2021 - Wiley Online Library
Objectives Endoxifen is a protein kinase C inhibitor. The objective of the present phase III
study was to demonstrate the safety and efficacy of endoxifen in treating bipolar I disorder (…
study was to demonstrate the safety and efficacy of endoxifen in treating bipolar I disorder (…
[Experts' Opinion] Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer
…, N Joshi, J Sejpal, D Bunger, M Khan - Oncology …, 2018 - spandidos-publications.com
The management of breast cancer with advanced disease or metastasis is a common problem
in India and other countries. A panel of 13 oncology experts deliberated on the sidelines …
in India and other countries. A panel of 13 oncology experts deliberated on the sidelines …
A multicenter, retrospective study (RE-ENACT 2) on Razumab™(World's First Biosimilar Ranibizumab) in retinal vein occlusion
S Sharma, M Khan, A Chaturvedi - Ophthalmology and Therapy, 2020 - Springer
Purpose The REal life assessmENt of safety And effeCTiveness of Razumab 2 (RE-ENACT
2) study evaluated the long-term effectiveness of biosimilar ranibizumab. We present the …
2) study evaluated the long-term effectiveness of biosimilar ranibizumab. We present the …
[PDF][PDF] Nutrient availability and maize (Zea mays) growth in soil amended with organic manures
Organic manures help to improve soil physical, chemical and biological properties thus
improve nutrient availability to crops. This experiment was conducted to evaluate the beneficial …
improve nutrient availability to crops. This experiment was conducted to evaluate the beneficial …
[HTML][HTML] Thymoquinone with metformin decreases fasting, post prandial glucose, and HbA1c in type 2 diabetic patients
…, M Paithankar, B Desai, P Patel, M Khan… - Drug …, 2021 - thieme-connect.com
Objective Antihyperglycemic activity of Thymoquinone (TQ) was evaluated in diabetic mouse
model and patients. Methods TQ (50 mg/kg) was orally administered daily for 21 days in …
model and patients. Methods TQ (50 mg/kg) was orally administered daily for 21 days in …
